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Abstract
Interferon regulatory factor (IRF) 8 and IRF4 are structurally-related, hematopoietic cell-specific transcription factors that
cooperatively regulate the differentiation of dendritic cells and B cells. Whilst in myeloid cells IRF8 is known to modulate
growth and differentiation, the role of IRF4 is poorly understood. In this study, we show that IRF4 has activities similar to
IRF8 in regulating myeloid cell development. The ectopic expression of IRF4 in myeloid progenitor cells in vitro inhibits cell
growth, promotes macrophages, but hinders granulocytic cell differentiation. We also show that IRF4 binds to and activates
transcription through the IRF-Ets composite sequence (IECS). Furthermore, we demonstrate that Irf8
-/-Irf4
-/- mice exhibit a
more severe chronic myeloid leukemia (CML)-like disease than Irf8
-/- mice, involving a disproportionate expansion of
granulocytes at the expense of monocytes/macrophages. Irf4
-/- mice, however, display no obvious abnormality in myeloid
cell development, presumably because IRF4 is expressed at a much lower level than IRF8 in granulocyte-macrophage
progenitors. Our results also suggest that IRF8 and IRF4 have not only common but also specific activities in myeloid cells.
Since the expression of both the IRF8 and IRF4 genes is downregulated in CML patients, these results may add to our
understanding of CML pathogenesis.
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Introduction
Cell differentiation requires appropriate changes in gene
expression patterns, which are tightly regulated by cell type-
specific transcription factors. In case of hematopoiesis, dysregula-
tion of these processes can result in hematopoietic disorders such
as leukemias [1]. Myeloid progenitor cells, defined as granulocyte-
macrophage progenitors (GMPs) [2], give rise to granulocytes
(such as neutrophils) or monocytes/macrophages. A number of
transcription factors including PU.1, C/EBPs and Interferon
Regulatory Factor 8 (IRF8) have been shown to regulate this
process. While PU.1 is essential for macrophage differentiation in
particular, C/EBPa and C/EBPe are the critical drivers of
granulocyte differentiation [3]. We have shown previously that
IRF8, a hematopoietic cell-specific factor belonging to the IRF
family, directs macrophage differentiation whilst it inhibits
myeloid cell growth and neutrophil differentiation [4,5]. We have
also previously identified an IRF8’s target DNA element termed
the IRF-Ets Composite Element (IECS; represented by
GAAANN[N]GGAA) and multiple direct target genes including
those encoding Blimp-1, Cathepsin C and Cystatin C [6,7].
Importantly, mice lacking the Irf8 gene (Irf8
-/- mice) develop a
chronic myelogenous leukemia (CML)-like syndrome, in which
there is a disproportionate expansion of neutrophils at the expense
of monocytes/macrophages [8,9,10]. Furthermore, cells from
human CML patients lack the expression of IRF8 [11], suggesting
that its loss is a key aspect of human CML pathogenesis.
Conservation of IRF8’s function between mice and humans has
been proven by a recent study demonstrating that a loss-of-
function mutation in the human IRF8 gene also results in a very
high neutrophil count and an absence of circulating monocytes
and dendritic cells [12].
IRF4 is another hematopoietic cell-specific IRF and has the
highest amino acid sequence similarity with IRF8. Consistent with
this structural similarity, both IRFs have an ability to interact with
the Ets transcription factor PU.1, required also for B cell
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Composite Element (EICE; GGAANNGAAA) [13]. The EICE is
another DNA sequence targeted by IRF and PU.1, and is active at
the promoters of B cell-specific genes such as immunoglobulin
light chain genes. In fact, IRF4 and IRF8 are expressed in B
lineage cells and cooperatively stimulate the development of B cells
[14]. In dendritic cells (DCs) consisting of multiple subsets, these
two IRFs are expressed in a subset-selective manner and govern
the generation of corresponding subsets [15,16] via their common
and specific activities [16]. It has been reported also that IRF4, like
IRF8, is expressed in macrophages [17]. However, the role of
IRF4 in myeloid cell development remains poorly understood. In
our current study, we have examined whether IRF4 has any roles
in regulating myeloid cell growth and differentiation through gene
introduction experiments and through the analysis of mice lacking
Irf4 and/or Irf8.
Materials and Methods
Ethics statement
All animal experimentations were conducted in accordance
with NIH and Public Health Service (PHS) policy or the
Guidelines for Proper Conduct of Animal Experiments (Science
Council of Japan), and all protocols were approved by Eunice
Kennedy Shriver NICHD Animal Care and Use Committee
(Protocol #08-010) or institutional review boards in Yokohama
City University (Protocol #09-127, 10-122).
Cells, retroviral vectors, retroviral transduction and mice
Tot2 and 32Dcl.3 cells were cultured as described previously in
the presence of granulocyte-macrophage colony stimulating factor
(Peprotech) at 2.5 ng/ml and 10% WEHI3B-conditioned medium
as a source of interleukin-3 (IL-3), respectively [4]. When inducing
neutrophil differentiation in 32Dcl.3 cells, granulocyte-colony
stimulating factor (G-CSF, Peprotech) was used at 10 ng/ml. To
generate pMSCV-puro (Clontech) and pMSCV-CD8t [7] vectors
carrying IRF8FLAG or IRF4FLAG, the FLAG peptide sequence
was added to the 39 side of Irf4 or Irf8 cDNA before the stop codon
by PCR using Pfu DNA polymerase. The resulting fragments were
then inserted into the vectors. pSIRV-IECS-Ld40-GFP has been
described previously [7]. pSIRV-mIECS-Ld40-GFP was con-
structed by inserting three copies of a mutant IECS fragment
(GAAACAGGGAA to GCTGCAGGGAA) into pSIRV-GFP.
The nucleotide sequences of all constructs were confirmed by
sequencing. Retroviral preparation and transduction were per-
formed as described previously [7]. Transduced cells were purified
by puromycin treatment (2 mg/mL) or immunomagnetic cell
sorting. Irf8
-/-, Irf4
-/-, and Irf8
-/-Irf4
-/- mice in a C57BL/6
background were described previously [16] and used at 7 to 9
weeks of age.
Quantitative RT-PCR
Total RNA was prepared using RNAiso Plus (Takara Bio),
treated with DNase I (Invitrogen), and reverse transcribed using
Primescript (Takara Bio) in accordance with the manufacturer’s
instructions. Quantitative PCR (qPCR) was performed in triplicate
using the THUNDERBIRD SYBR qPCR Mix (Toyobo) and the
ABI 7500 or StepOnePlus real-time PCR systems (Applied
Biosystems) according to the manufacturers’ protocols. The
following primers were used: Msr1 (sense, 59-ATC ACC AAC
GAC CTC AGA CT-39; antisense, 59-CCG ATC ACC TTT
AAC ACC T-39), Irf5 (sense, 59-ATG TCC TGG ACC GTG
GGC TC-39; antisense, 59-GAA CAC CTT ACA CTG GCA
CAG ACG-39), Mrc1 (sense, 59-AGC CCA CAC CTG CTC CAC
AAG A-39; antisense, 59-GCT CGC GCG TTG TCC ATG
GTT-39), Il12b (sense, 59-GAC ACG CCT GAA GAA GAT
GAC-39; antisense, 59-TAG TCC CTT TGG TCC AGT GTG-
39), Il6 (sense, 59-AGT TGC CTT CTT GGG ACT GA-39;
antisense, 59-TCC ACG ATT TCC CAG AGA AC-39), Csf3r
(sense, 59-CCC ACC ATC ATG ACA GAG-39; antisense, 59-
CAG TGG GTC GGT TTC TTG T-39), Irf4 (sense, 59-TCG
GCC CAA CAA GCT AGA AA-39; antisense, 59-GGC CAT
GGT GAG CAA ACA CT-39), Irf8 (sense, 59-ATA TGC CGC
CTA TGA CAC ACA CC-39; antisense, 59-TTG CCC CCG
TAG TAG AAG CTG A-39). The primers used to analyze the
other genes tested in this study were as previously described
[6,7,16]. Each of the primer sets produced a unique product. Data
were analyzed using either the DDCT method or the standard
curve method, and normalized against the Gapdh expression levels.
Flow cytometry
For cell-surface marker analysis, cells were stained as described
previously [16] with the appropriate antibodies and analyzed by
FACSCalibur or FACSCanto II (BD Biosciences). A phagocytosis
assay was performed using Vybrant Phagocytosis Assay Kit
(Invitrogen). In this experiment, the cells were incubated with
fluorescein-labeled E. coli K-12 bioparticles at 37uC for 2 h, then
washed twice before analysis by flow cytometry. As a control
reaction, cells were incubated at 4uC. The resulting data were
analyzed using the FlowJo software (TreeStar). For cell cycle
analysis, cells were fixed in cold 70% ethanol, treated with
100 ng/mL RNaseA, and stained with 50 mg/mL propidium
iodide. Stained cells were analyzed by FACSCalibur and cell cycle
profiles obtained by using CellQuest and ModFitLD V2.0
software (BD Biosciences). Cell sorting was performed using
FACSAria II (BD Biosciences) or MoFlo (Dako Cytomation) into
the following lineages: common myeloid progenitors (CMPs), Lin
2
(lineage marker-negative, CD5
2 B220
2 CD11b
2 Gr1
2 7/
4
2Ter119
2), IL-7Ra
2 c-Kit
+ Sca-1
2 CD34
+ FccRII/III
2;
GMPs, Lin
2 IL-7Ra
2 c-Kit
+ Sca-1
2 CD34
+ FccRII/III
+;
granulocytes, CD11c
2 CD11b
+ F4/80
2 Gr1
+; T cells, CD3
+;B
cells, CD19
+; plasmacytoid DCs (pDCs), CD11c
+ PDCA-1
+
B220
+; and classical DCs (cDCs), CD11c
+ PDCA-1
2 B220
2.
CMPs and GMPs were obtained from bone marrow. Lin
2 cells
were enriched by the Lineage Cell Depletion Kit and the
AutoMACS cell separation system (Miltenyi Biotec). Resident
macrophages were obtained from the peritoneal cavity and
purified using plastic plate adherence. Other cell types were
obtained from the spleen. The purity of the sorted cells was
.95%. 7-Amino-Actinomycin D (eBioscience) was used to exclude
dead cells. Antibodies were purchased from BD Pharmingen,
eBioscience or BioLegend.
Reporter Assay
Reporter assays were performed as described previously [7]
with slight modifications. Briefly, cells were transduced with
SIRV-IECS-Ld40-GFP or SIRV-mIECS-Ld40-GFP reporter
constructs, selected with puromycin, and then transduced with
MSCV-CD8t vectors harboring IRF4FLAG or IRF8FLAG.
Transduced cells were stained with anti-human CD8 conjugated
with Cy-Chrome (BD Pharmingen). The promoter activities were
analyzed using a FACSCanto II on day 2 after the transduction of
MSCVs to acquire GFP signals in CD8
+ cells. The data were
analyzed using FlowJo software (TreeStar).
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assays were performed
as described previously [7] with slight modifications. Briefly, cell
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using Bioruptor (Cosmo Bio) to shear the genomic DNA into 200-
to 1000-base pair fragments. Immunoprecipitations were then
performed using 2 mg of normal goat immunoglobulin G (IgG),
goat anti-IRF8 antibody (C-19; Santa Cruz Biotechnology) or goat
anti-IRF4 antibody (M-17; Santa Cruz Biotechnology). The
primers used for qPCR were as described previously [7]. Data
were analyzed using the DDCT method.
Results
IRF4 induces macrophage differentiation and cell cycle
arrest
We have previously shown that the introduction of IRF8 into
Irf8
-/- myeloid progenitor cell lines such as Tot2 causes their
differentiation into mature macrophages concomitant with a cell
cycle arrest at the G0/G1 phase. To examine whether IRF4 has a
similar function, we introduced this factor into Tot2 cells using a
MSCV retrovirus (MSCV-IRF4FLAG-puro). As shown in
Figure 1A, IRF4-transduced cells manifested morphologic changes
typical of macrophages, i.e., enlargement of the cytoplasm filled
with vacuoles, and shrinkage and condensation of nucleus by day 6,
which were similar also to those observed in cells transduced with
IRF8-FLAG. Flow cytometry analysis demonstrated that these
morphological changes accompanied the expression of CD11b, F4/
80 and M-CSF receptor, and also the loss of Gr-1 expression
(Figure 1B). Furthermore, IRF4-transduced cells exhibited strong
phagocytic activity that was comparable to IRF8-transduced cells,
whilst control MSCV-transduced cells did not show this activity
(Figure 1C). These results indicate that the transduction of IRF4 or
IRF8 cells results in their differentiation into bona fide macrophag-
es. Immunoblotting analysis using an anti-FLAG antibody showed
that the expression level of the introduced IRF4 was considerably
lower than that of IRF8, suggesting a comparable or greater ability
of IRF4 than IRF8 to cause morphological macrophage differen-
tiation (Figure 1D). Of note, Tot2 cells do not express detectable
levels of endogenous Irf4 by semi-quantitative RT-PCR (data not
shown), which would explain the strong dependence of this cell line
on exogenous IRF8 or IRF4 for macrophage differentiation (also
see below for the detection of Irf4 expression in GMPs using a more
sensitive qRT-PCR method).
qRT-PCR analysis revealed that various macrophage-related
genes such as those encoding Cathepsin C (Ctsc), Cystatin C (Cst3),
CSF-1 receptor/M-CSF receptor (Csf1r), Scavenger receptor (Msr1)
and Blimp-1 (Prdm1), known to be induced by IRF8 [6,7], are also
strongly induced upon the introduction of IRF4, whereas IRF2
failed to induce Ctsc or Cst3 (Figure 2A). On the other hand, both
IRF4 and IRF8 inhibited the expression of the Cebpe gene that
encodes C/EBPe, a transcription factor essential for neutrophil
differentiation. In the case of Cst3, its induction by IRF4 was
somewhat weaker than that by IRF8 but was still reproducibly
detectable. Blimp-1 is a transcription factor that represses the Myc
gene. Myc expression was in fact suppressed, and the cell cycle
largely arrested at G0/G1, in cells transduced with IRF4 or IRF8
(Figure 2B). Interestingly, we further found that IRF4 and IRF8
induce the gene encoding IRF5, another IRF that is preferentially
expressed in immune cells including macrophages (see below).
These results indicate that IRF4 has abilities that are similar to
IRF8 in directing myeloid progenitor cells to differentiate towards
macrophages and inducing cell growth arrest.
Activation of IECS-mediated transcription by IRF4
To next examine the mechanism by which IRF4 induces
macrophage differentiation, we analyzed whether IRF4 targets the
IECS, which was originally identified as the DNA element
targeted by IRF8 in differentiating macrophages [7]. We first
performed reporter assays using the self-inactivating retrovirus-
based reporter, SIRV-GFP [7]. Tot2 cells were first transduced
with SIRV-IECS-Ld40-GFP (in which GFP transcription is driven
by three copies of the IECS from Cst3, a direct target gene of
IRF8, followed by the minimal promoter Ld40) or SIRV-mIECS-
Ld40-GFP (in which the core IRF binding sequence GAAA in the
IECS is mutated), and further transduced with IRF4 or IRF8. The
promoter activity levels were then quantified by measuring the
GFP expression levels. The results showed that both IRFs strongly
induced transcription via the IECS but not the mIECS containing
promoters (Figure 3A).
We next performed chromatin ChIP assays using the same
system, i.e. Tot2 cells transduced with SIRVs and IRFs. As shown
in Figure 3B, both IRF4 and IRF8 bound to the IECS but not
mIECS within the SIRV reporter cassette. As expected, this
binding was not observed in empty MSCV-transduced cells.
Likewise, both IRF4 and IRF8 bound to the endogenous Cst3 gene
promoter that contains an IECS (Figure 3C). Thus, IRF4 and
IRF8 show a common ability to bind to, and thereby activate
transcription, via the IECS.
Specific activities of IRF4 and IRF8
We wished to next determine whether the activities of IRF4 and
IRF8 in myeloid cells are equivalent. To address this question, we
screened the expression of various genes in Tot2 cells 3 days after
the transduction of IRF4, IRF8, or an empty vector. The Tot2
system was used in order to compare the activities of these IRFs in
an early phase of macrophage differentiation on the same
platform. Although many macrophage-related genes are induced
by both IRF4 and IRF8 as shown in Figure 2A, we found that
there are genes specifically induced by only one of these two IRFs.
For example, the Mmp12 and Mrc1 genes, encoding matrix
metalloproteinase-12 and the CD206/mannose receptor and
CD169, respectively, were found to be specifically induced by
IRF4, whereas Itgae (encoding integrin aE) was only activated by
IRF8 (Figure 4A). These results suggest that IRF4 and IRF8 also
have separate functions in macrophages.
Regulation of the innate immune responses by IRF4
To compare the impact of IRF4 and IRF8 upon TLR signaling,
Tot2-derived macrophages generated by the transduction of either
IRF4 or IRF8 were stimulated with the TLR4 ligand lipopoly-
saccharide (LPS) or the TLR9 ligand CpG DNA. The induction of
Il12b and Il6 mRNAs was then measured. Consistent with the
known role of IRF8 in Il12b transcription and TLR9 signaling,
macrophages generated via IRF8 displayed much higher induction
of Il12b upon both LPS and CpG treatment, and of Il6 upon CpG
treatment, compared with those generated by IRF4, although the
latter cells showed low but measurable responses despite the lack of
IRF8 expression (Figure 4B). Surprisingly, the induction of Il6
upon LPS treatment was higher in IRF4-transduced macrophages
than in IRF8-transduced macrophages. The empty virus-trans-
duced Tot2 cells did not show any induction of either gene. These
results suggest that IRF4 may have a positive role, in addition to its
previously reported negative role [18,19], in TLR signaling and/
or the transcriptional regulation of cytokine genes.
As a possible mechanism, we found that both IRF4 and IRF8
strongly induce Irf5 transcripts in Tot2 cells (Figure 2A). It has
been shown that IRF5 binds to MyD88 upon recognition of
various TLR stimuli, and then activated IRF5 functions as a direct
transcriptional activator of multiple cytokine genes including Il6
and Il12b [20]. Thus, IRF5 may, in part, mediate the positive
Functions of IRF4 and IRF8 in Myeloid Cells
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macrophages.
IRF4 inhibits neutrophil differentiation
We next sought to determine whether IRF4 has an ability to
regulate neutrophil differentiation in a similar manner to IRF8. To
this end, we employed 32Dcl.3 myeloid progenitor cells, which
differentiate towards neutrophils when the supplemented cytokine
is switched from IL-3 to G-CSF. In the presence of IL-3, the
transduction of IRF4 or IRF8 did not affect cell viability or the
proliferation of 32Dcl.3 cells (Figure 5A and C). In empty vector-
transduced control cells, a 7-day culture with G-CSF showed
morphological changes typical of neutrophils such as band/
segmented nuclei in approximately 40% of the cells, whereas in
Figure 1. IRF4 drives the differentiation of myeloid progenitors towards macrophages. (A) Wright-Giemsa stain of Tot2 cells transduced
with empty MSCV-puro, MSCV-IRF4FLAG-puro or MSCV-IRF8FLAG-puro (original magnification, x 600). (B) Surface marker analysis. Cells on day 6 were
stained with the indicated antibodies or isotype control antibodies and analyzed by flow cytometry. Note that differentiated macrophages have
higher autofluorescence than undifferentiated cells. (C) Phagocytic activity. Cells on day 6 were incubated with fluorescein-labeled E. coli bioparticles
at 37uCo r4 uC for 2 h and analyzed by flow cytometry. (D) Immunoblotting analysis of FLAG-tagged IRFs. b-tubulin expression is shown as a loading
control.
doi:10.1371/journal.pone.0025812.g001
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resulted in the appearance of mostly immature intermediate cells
(Figure 5A and D). The expression levels of the introduced IRF4
and IRF8 were comparable (Figure 5B) and qRT-PCR analysis of
the IRF4 or IRF8-transduced cells revealed that the induction of
the gene encoding G-CSF receptor (Csf3r) upon G-CSF treatment
was three-fold lower than in the control cells (Figure 5E). Indeed,
the growth response to G-CSF was approximately seven-fold less
than that of the control cells (Figure 5F). These results indicate that
both IRF4 and IRF8 have an ability to inhibit neutrophil growth
and differentiation.
A more severe CML-like disease in mice doubly deficient
for Irf4 and Irf8
To gain insight into the role of endogenous IRF4 in myeloid cell
development, we analyzed mice that are deficient in Irf8, Irf4 or both
(Irf8
-/-, Irf4
-/- or DKO, respectively). Splenomegaly, known to occur
in Irf8
-/- mice [8], was not observed in Irf4
-/- mice at the age
examined (7–9 weeks). However, DKO mice exhibited a more severe
splenomegaly than Irf8
-/- mice (Figure 6A), indicating a possible role
of IRF4 that might be ‘‘hidden’’ if Irf8 is intact. Flow cytometric
analysis of splenocytes and bone marrow cells revealed that the
increase in both the percentages and absolute numbers of CD11b
+
Gr1
+ granulocytes, known to occur in Irf8
-/- mice, was markedly
augmented in DKO mice, whilst Irf4
-/- mice did not show an obvious
increase (Figure 6B and C). On the other hand, the F4/80
+
macrophage counts, known to decrease in Irf8
-/- mice, were more
severely diminished in DKO mice. Accordingly, the ratios of the
granulocyte to macrophage numbers in the spleens of WT, Irf8
-/-,
Irf4
-/-, and DKO mice were 3.3, 88.1, 6.0, and 1023.5, respectively
(Figure 6C). Taken together, our data reveal that DKO mice exhibit
a more severe myeloid development abnormality resembling CML
compared with Irf8
-/- mice, in which there is a disproportionate
expansion of granulocytes at the expense of monocytes/macrophag-
es. After we completed this work, Ren and colleagues also reported
the expansion of granulocytes in Irf4
-/-Irf8
-/- mice [21]. In addition,
the authors investigated the long-term fate of the mutant mice to
show cooperative tumor suppressive functions for IRF4 and IRF8 in
both myeloid and lymphoid cells.
Expression of Irf4 and Irf8 mRNAs at various
differentiation stages in hematopoietic cells
To better understand why the loss of Irf4 alone does not cause
obvious abnormalities in myeloid cell development, whilst DKO
Figure 2. IRF4 induces macrophage-related genes and growth arrest during macrophage differentiation. (A) Induction of macrophage-
related genes. Transcript levels in MSCV-transduced cells on day 5 were analyzed by qRT-PCR in triplicate. Data were analyzed using the DDCT
method and normalized by the Gapdh levels and shown as values relative to those in empty vector-transduced cells (mean 6 standard deviation;
representative of three independent experiments with similar results). *P,0.01 (Student’s t-test). (B) Total viable cell yields (left panel) and cell cycle
profiles (on day 4, right panel) after the transduction of MSCVs. Data are expressed as mean 6 standard deviation of three independent experiments.
*P,0.01 (Student’s t-test).
doi:10.1371/journal.pone.0025812.g002
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-/- mice, we examined the
expression of endogenous Irf4 and Irf8 in CMPs, GMPs,
macrophages and granulocytes, along with several other types of
hematopoietic/immune cells. Whereas Irf8 was clearly expressed
in CMPs and GMPs, the expression of Irf4 was very low in both of
these progenitors (Figure 7A). This result provides a basis of the
role of IRF8 being predominant and that of IRF4 becoming visible
only when IRF8 is absent in myeloid progenitor cells. The Irf4
transcript levels in Irf8
-/- GMPs were found to be comparable with
those in WT GMPs, indicating that it is unlikely that IRF8
functions as an IRF4 inducer (Figure 7B). Consistent with the
common functions of these IRFs in stimulating and inhibiting the
differentiation of macrophages and granulocytes, respectively, the
expression of both Irf4 and Irf8 was found to be increased in
macrophages but decreased to very low levels in granulocytes
(Figure 7A).
Discussion
We demonstrate in our current study that IRF4 has similar
functions to IRF8 in the regulation of differentiation and growth in
myeloid cells. Moreover, our present data suggest that each of
these IRFs also has separate functions in macrophages.
In vitro differentiation experiments showed that IRF4, like IRF8,
inhibits myeloid cell growth, and tunes the balance of lineage
selection in myeloid progenitor cells by stimulating macrophage
differentiation whilst inhibiting neutrophil differentiation. The
results of reporter and ChIP assays revealed that IRF4 directly
targets the IECS to activate the transcription of macrophage-
related genes, clearly indicating that IRF4, as well as IRF8,
Figure 3. IRF4 targets the IECS. (A) Reporter assays of transcription
through the IECS. Tot2 cells were transduced with SIRV-IECS-Ld40-GFP
or SIRV-mIECS-Ld40-GFP and then with empty MSCV-CD8t, MSCV-IRF4-
CD8t, or MSCV-IRF8-CD8t. The promoter activities in CD8
+ cells were
analyzed on day 2 after the transduction of MSCVs. The activity is
shown as mean fluorescent intensity (MFI) of GFP signals (mean 6
standard deviation of three independent experiments). *P,0.01
(Student’s t-test). (B, C) ChIP assays for binding to the IECS (B) or a
gene promoter containing an IECS (C). Cells transduced with SIRVs and
MSCVs were analyzed by ChIP assays on day 3 after the transduction of
MSCVs. Chromatin was precipitated by anti-IRF4 antibody, anti-IRF8
antibody, or normal goat IgG. Precipitated DNA was analyzed by qPCR
in triplicate using primers that amplified the IECS sequence in SIRVs or
those that amplified the IECS region of the Cst3 gene promoter (mean
6 standard deviation). Data are representative of three independent
experiments. *P,0.01 (Student’s t-test).
doi:10.1371/journal.pone.0025812.g003
Figure 4. Specific activities of IRF4 and IRF8 in macrophages.
(A) Genes specifically induced by IRF4 or IRF8. Tot2 cells transduced
with empty MSCV-puro, MSCV-IRF4FLAG-puro or MSCV-IRF8FLAG-puro
were analyzed by qRT-PCR on day 3 (mean 6 standard deviation). Data
are representative of two independent experiments with similar results.
(B) Distinct patterns of cytokine gene induction in IRF4- and IRF8-
transduced macrophages. Cells transduced with MSCVs were stimulat-
ed on day 5 with 1 mg/ml LPS or 1 mg/ml CpG-B for 5 h, and analyzed
by qRT-PCR using the DDCT method (mean 6 standard deviation). Two
repeat experiments gave similar results. *P,0.01 (Student’s t-test).
doi:10.1371/journal.pone.0025812.g004
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findings, Irf8
-/-Irf4
-/- mice display more severe CML-like symp-
toms than Irf8
-/- mice. However, mice singly deficient in Irf4 did
not show any obvious abnormalities in their granulocyte and
macrophage counts. One possible reason for this is the differential
expression levels of IRF4 and IRF8 in myeloid progenitors (CMPs
and GMPs). We observed by qRT-PCR that the expression level
of Irf8 in CMPs and GMPs is far higher than that of Irf4, whilst
both IRF genes were clearly expressed in macrophages and at very
low levels in granulocytes. We propose that during lineage
selection in GMPs i.e. differentiation into macrophages or
granulocytes, the role of IRF8 predominates but IRF4, expressed
at a low level, can partially compensate for the absence of IRF8.
The activities of IRF4 and IRF8 in myeloid cells are not fully
equivalent however. Whereas many macrophage-related genes
such as Ctsc, Cst3, Csf1r, Msr1, Prdm1, and Irf5 are induced both by
IRF4 and IRF8, several genes were found to be induced by only
one of the two IRFs. Specifically, IRF4 induces Mmp12 and Mrc1,
whilst only IRF8 induces Itgae. The specific induction of Mmp12
and Itgae is reminiscent of a similar observation made previously in
dendritic cells [16]. Mannose receptor is an M2 macrophage-
related molecule [22] (see also below). Global gene expression
profiling by microarray analysis supports the presence of both
common and specific downstream genes for IRF4 and IRF8 (A.N.,
M.Y. and T.T., unpublished results). These results suggest that
they have both common and specific activities, which are likely to
confer basic features and functional diversity, respectively, upon
macrophages.
It has been reported that IRF4 and IRF8 play distinct roles in
innate immune responses. For example, IRF4 and IRF8 have been
shown to affect the TLR-MyD88 pathway negatively and
positively, respectively [18,19,23,24]. Only IRF8 is induced by
IFN-c, the cytokine once referred to as the macrophage-activating
factor, and participates in the transcriptional activation of IL-
12p40 [25,26]. Our present data indeed demonstrate that IRF8 is
far more potent than IRF4 in supporting TLR9 signaling and
inducing the Il12b gene. Whilst the accumulating evidence
suggests that IRF8 is essential for M1 macrophage polarization
via the induction of IL-12p40, Akira and colleagues have reported
very recently that IRF4 is essential for the M2 polarization [27].
We also observed that IRF4 but not IRF8 induces Mrc1, that
encodes an M2 macrophage-related molecule [22]. Yet, our
current study indicates a more complex picture of the role played
by IRF4; it stimulates LPS (but not CpG) induction of the gene
encoding the M1 cytokine IL-6 more strongly than IRF8 [22]. The
‘‘positive’’ effects of IRF4 on the innate immune responses may be
mediated, at least in part, by the induction of Irf5 because IRF5 is
essential for the signaling that occurs through various TLRs and is
implicated in the transcriptional activation of multiple cytokine
genes including Il6 [20]. However, the induction of Irf5 occurs also
via IRF8, suggesting that this represents a previously unrecognized
‘‘common and positive’’ effect of IRF4 and IRF8 on the innate
Figure 5. Inhibition of neutrophil differentiation by IRF4. (A) Wright-Giemsa staining of 32Dcl.3 cells transduced with empty MSCV-puro,
MSCV-IRF4FLAG-puro or MSCV-IRF8FLAG-puro and cultured in the presence of IL-3 (upper panels) or G-CSF (for 7 days, lower panels). (B)
Immunoblotting analysis of FLAG-tagged IRFs. b-tubulin expression is shown as a loading control. (C) Cell growth curves in the presence of IL-3. Data
are expressed as mean 6 standard deviation of triplicate determinations. (D) Proportions of cells showing the morphologic characteristics of mature
granulocytes. *P,0.01 (Student’s t-test). (E) Csf3r mRNA expression levels after 7 days of treatment of G-CSF. The expression levels were determined
by qRT-PCR using the DDCT method (mean 6 standard deviation). Data are representative of two independent experiments with similar results.
*P,0.01 (Student’s t-test). (F) Viable cell yields during treatment with G-CSF. Data are expressed as mean 6 standard deviation of three independent
experiments.
doi:10.1371/journal.pone.0025812.g005
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positive’’ potential of IRF4 requires further investigation. Because
the heterogeneity of macrophages has been progressively uncov-
ered, it will be important to further investigate the usage of IRF4
and IRF8 in different macrophage subsets.
It is noteworthy that IRF4 and IRF8 are essential for the
development of all professional antigen presenting cells (APCs)
including macrophages (this study), DCs and B cells [14,16,28]. In
these APCs, IRF4 typically stimulates Th2 responses, whilst IRF8
induces Th1 responses [16,27,29,30]. Furthermore, IRF4 and
IRF8 also play a role in T cells where IRF4 is required for Th2,
Th17 and Th9 responses, whereas IRF8 inhibits Th17 responses
[31,32,33,34]. Hence, the similar but distinct transcription factors
IRF4 and IRF8, which are present only in vertebrates, make a
critical contribution to diverse immune responses by acting in
professional APCs as well as in T cells, both of which are the
hallmark of the vertebrate immune system.
It has been shown previously that not only IRF8 but also IRF4
transcript levels are significantly diminished in human CML
patients [11,35,36]. Moreover, IRF8 and IRF4 expression
correlates with the cytogenetic response to IFN-a. Importantly,
these observations are not secondary phenomena due to the
expansion of neutrophils that do not express these IRFs, because
the expression of IRF8 and IRF4 is also diminished in sorted B and
T cells, respectively. The Bcr/Abl kinase inhibitor imatinib has
replaced IFN-a as the first-line therapy for CML. However, this
inhibitor cannot effectively eliminate leukemic stem cells [37,38],
and if the drug is discontinued, most patients eventually relapse.
The next generation of therapies for CML is thus eagerly awaited.
Notably, it is well established that CML cells are highly sensitive to
T cell-mediated immunity [39]. Naı ¨ve T cells are activated by
professional APCs, particularly DCs and macrophages, whose
differentiation and function are cooperatively regulated by IRF8
and IRF4, as revealed by the current and previous studies. In this
regard, it will be interesting to more closely examine whether
CML patients have any defects in the development and function of
their professional APCs. Thus, the lack of IRF8 and IRF4
expression is likely to be critically involved in the pathogenesis of
Figure 6. A CML-like disease in mice deficient for Irf8 and Irf4. (A) Spleens (left panel) and spleen weight of WT, Irf8
-/-, Irf4
-/-, and DKO mice.
Values are mean 6 standard deviation from measurements of 5 to 6 spleens of each genotype. *P,0.01 (Student’s t-test). (B) Flow cytometric analysis
of granulocytes (CD11b
+ Gr1
+) and macrophages (F4/80
+) in bone marrow cells (upper panels) and splenocytes (lower panels). Numbers indicate the
percentages of granulocytes and macrophages. Data are representative of three independent experiments with similar results. (C) The absolute
numbers of granulocytes and macrophages per femur (upper part) or spleen (lower part). The ratios of granulocytes to macrophages are shown in
the right panels. Values are mean 6 standard deviation from 3 to 5 mice of each genotype. *P,0.01 and **P,0.05 (Student’s t-test).
doi:10.1371/journal.pone.0025812.g006
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function of these IRFs could be a powerful new approach to the
improvement of CML therapy.
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